Cargando…
Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis
OBJECTIVE: FX006 is a novel, microsphere‐based, extended‐release formulation of triamcinolone acetonide for intraarticular (IA) injection designed to maintain treatment concentration in the joint and provide prolonged analgesic benefits in patients with osteoarthritis (OA) of the knee. This study wa...
Autores principales: | Conaghan, Philip G., Cohen, Stanley B., Berenbaum, Francis, Lufkin, Joelle, Johnson, James R., Bodick, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814922/ https://www.ncbi.nlm.nih.gov/pubmed/29088579 http://dx.doi.org/10.1002/art.40364 |
Ejemplares similares
-
Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study
por: Conaghan, Philip G., et al.
Publicado: (2018) -
Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study
por: Russell, Steven J, et al.
Publicado: (2018) -
Machine-learning, MRI bone shape and important clinical outcomes in osteoarthritis: data from the Osteoarthritis Initiative
por: Bowes, Michael A., et al.
Publicado: (2021) -
A randomized, phase IIa study to assess the systemic exposure of
triamcinolone acetonide following injection of extended-release triamcinolone
acetonide or traditional triamcinolone acetonide into both knees of patients
with bilateral knee osteoarthritis
por: Kivitz, Alan, et al.
Publicado: (2019) -
Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis
por: Langworthy, Michael J., et al.
Publicado: (2019)